Literature DB >> 26464241

Comparative Effects of Bile Diversion and Duodenal-Jejunal Bypass on Glucose and Lipid Metabolism in Male Diabetic Rats.

Xiang Zhang1,2, Teng Liu1, Yanmin Wang1, Mingwei Zhong1, Guangyong Zhang1, Shaozhuang Liu1, Tongzhi Wu2, Christopher K Rayner2, Sanyuan Hu3.   

Abstract

BACKGROUND: Duodenal-jejunal bypass (DJB) induces rapid and durable improvement in glucose and lipid metabolism. Besides bypassing the proximal gut, DJB also diverts bile acids (BAs) into the distal gut, increasing luminal and systemic BAs that are essential to metabolic homeostasis. The aim of this study is to evaluate whether bile diversion (BD) alone can recapitulate the effects of DJB on glucose and lipid metabolism.
METHODS: BD, DJB and SHAM procedures were performed in a diabetic rat model induced by high-fat diet (HFD)/streptozotocin (STZ). Body weight, energy intake, blood glucose, serum hormones, insulin sensitivity, lipid profiles, and luminal and systemic BAs were measured postsurgery.
RESULTS: BD reduced body weight, independently of energy intake, whereas DJB had no effects. Luminal and serum BAs were increased after both DJB and BD, and were higher after BD than DJB. During glucose tolerance test, both fasting and postprandial blood glucose concentrations were reduced with DJB and BD, and were lower after DJB than BD. Insulin sensitivity was improved after DJB, but remained unchanged after BD. Fasting and postprandial GLP-1 were equally increased after DJB and BD. Serum triglyceride and free fatty acids were decreased more after BD than DJB, while hepatic triglyceride storage was reduced more after DJB.
CONCLUSION: These observations indicate that BD, which increases luminal and systemic BAs and postprandial GLP-1, represents an important component of DJB in restoring glucose and lipid homeostasis in diabetic state. However, other mechanisms associated with DJB also appear to make complementary contributions to metabolic regulation.

Entities:  

Keywords:  Bile acids; Bile diversion; Diabetes mellitus; Duodenal-jejunal bypass

Mesh:

Substances:

Year:  2016        PMID: 26464241     DOI: 10.1007/s11695-015-1925-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

1.  Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine.

Authors:  Marek Drozdzik; Christian Gröer; Jette Penski; Joanna Lapczuk; Marek Ostrowski; Yurong Lai; Bhagwat Prasad; Jashvant D Unadkat; Werner Siegmund; Stefan Oswald
Journal:  Mol Pharm       Date:  2014-09-11       Impact factor: 4.939

2.  Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat.

Authors:  Bethany P Cummings; April D Strader; Kimber L Stanhope; James L Graham; Jennifer Lee; Helen E Raybould; Denis G Baskin; Peter J Havel
Journal:  Gastroenterology       Date:  2010-03-10       Impact factor: 22.682

3.  Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

Authors:  Ricardo Cohen; Pedro Paulo Caravatto; Jose Luis Correa; Patricia Noujaim; Tarissa Zanata Petry; João Eduardo Salles; Carlos Aurelio Schiavon
Journal:  Surg Obes Relat Dis       Date:  2012-02-02       Impact factor: 4.734

4.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

5.  Bile salt inhibition of motility in the isolated perfused rabbit terminal ileum.

Authors:  D N Armstrong; H K Krenz; I M Modlin; G H Ballantyne
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

6.  Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI).

Authors:  Almino C Ramos; Manoel P Galvão Neto; Yglésio Moyses de Souza; Manoela Galvão; Abel H Murakami; Andrey C Silva; Edwin G Canseco; Raúl Santamaría; Trino A Zambrano
Journal:  Obes Surg       Date:  2008-11-06       Impact factor: 4.129

7.  Steady-state kinetics of serum bile acids in healthy human subjects: single and dual isotope techniques using stable isotopes and mass spectrometry.

Authors:  G T Everson
Journal:  J Lipid Res       Date:  1987-03       Impact factor: 5.922

8.  Internal biliary diversion improves glucose tolerance in the rat.

Authors:  G Manfredini; M Ermini; L Scopsi; F Bonaguidi; E Ferrannini
Journal:  Am J Physiol       Date:  1985-10

9.  Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.

Authors:  T Wu; M J Bound; S D Standfield; B Gedulin; K L Jones; M Horowitz; C K Rayner
Journal:  Diabetes Obes Metab       Date:  2012-12-17       Impact factor: 6.577

10.  TGR5-mediated bile acid sensing controls glucose homeostasis.

Authors:  Charles Thomas; Antimo Gioiello; Lilia Noriega; Axelle Strehle; Julien Oury; Giovanni Rizzo; Antonio Macchiarulo; Hiroyasu Yamamoto; Chikage Mataki; Mark Pruzanski; Roberto Pellicciari; Johan Auwerx; Kristina Schoonjans
Journal:  Cell Metab       Date:  2009-09       Impact factor: 27.287

View more
  6 in total

Review 1.  Bile acids and bariatric surgery.

Authors:  Vance L Albaugh; Babak Banan; Hana Ajouz; Naji N Abumrad; Charles R Flynn
Journal:  Mol Aspects Med       Date:  2017-04-17

2.  Duodenal-jejunal bypass reduces serum ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway.

Authors:  Zhi-Qiang Cheng; Tong-Ming Liu; Peng-Fei Ren; Chang Chen; Yan-Lei Wang; Yong Dai; Xiang Zhang
Journal:  World J Gastroenterol       Date:  2022-08-21       Impact factor: 5.374

3.  Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2-hour plasma glucose in individuals without diabetes.

Authors:  Xuyi Wang; Chang Chen; Cong Xie; Weikun Huang; Richard L Young; Karen L Jones; Michael Horowitz; Christopher K Rayner; Zilin Sun; Tongzhi Wu
Journal:  Diabetes Obes Metab       Date:  2022-03-22       Impact factor: 6.408

4.  Cholecystectomy is associated with dysglycaemia: Cross-sectional and prospective analyses.

Authors:  Miaomiao Sang; Cong Xie; Shanhu Qiu; Xuyi Wang; Michael Horowitz; Karen L Jones; Christopher K Rayner; Zilin Sun; Tongzhi Wu
Journal:  Diabetes Obes Metab       Date:  2022-05-25       Impact factor: 6.408

5.  Improvement of Glucose Metabolism Following Long-Term Taurocholic Acid Gavage in a Diabetic Rat Model.

Authors:  Zhiqiang Cheng; Guozhi Liu; Xiang Zhang; Dongsong Bi; Sanyuan Hu
Journal:  Med Sci Monit       Date:  2018-10-09

Review 6.  Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease.

Authors:  Cong Xie; Weikun Huang; Richard L Young; Karen L Jones; Michael Horowitz; Christopher K Rayner; Tongzhi Wu
Journal:  Nutrients       Date:  2021-03-28       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.